PL373049A1 - Rutenowe kompleksy przeciwrakowe - Google Patents

Rutenowe kompleksy przeciwrakowe

Info

Publication number
PL373049A1
PL373049A1 PL03373049A PL37304903A PL373049A1 PL 373049 A1 PL373049 A1 PL 373049A1 PL 03373049 A PL03373049 A PL 03373049A PL 37304903 A PL37304903 A PL 37304903A PL 373049 A1 PL373049 A1 PL 373049A1
Authority
PL
Poland
Prior art keywords
ruthenium
anticancer complexes
ruthenium anticancer
complexes
formula
Prior art date
Application number
PL03373049A
Other languages
English (en)
Inventor
Peter John Sadler
Lainez Rafael Fernandez
Abraba Habtemariam
Michael Melchart
Duncan Ian Jodrell
Original Assignee
The University Court, The University Of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Court, The University Of Edinburgh filed Critical The University Court, The University Of Edinburgh
Publication of PL373049A1 publication Critical patent/PL373049A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL03373049A 2002-07-05 2003-07-04 Rutenowe kompleksy przeciwrakowe PL373049A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0215526.5A GB0215526D0 (en) 2002-07-05 2002-07-05 Anticancer compounds

Publications (1)

Publication Number Publication Date
PL373049A1 true PL373049A1 (pl) 2005-08-08

Family

ID=9939861

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373049A PL373049A1 (pl) 2002-07-05 2003-07-04 Rutenowe kompleksy przeciwrakowe

Country Status (20)

Country Link
US (1) US20060058270A1 (pl)
EP (1) EP1558620B1 (pl)
JP (1) JP2005536487A (pl)
KR (1) KR20050053589A (pl)
CN (1) CN100362005C (pl)
AT (1) ATE407937T1 (pl)
AU (1) AU2003251159B2 (pl)
BR (1) BR0312470A (pl)
CA (1) CA2491640A1 (pl)
DE (1) DE60323529D1 (pl)
DK (1) DK1558620T3 (pl)
ES (1) ES2314245T3 (pl)
GB (1) GB0215526D0 (pl)
MX (1) MXPA05000314A (pl)
NO (1) NO20050640L (pl)
NZ (1) NZ538005A (pl)
PL (1) PL373049A1 (pl)
PT (1) PT1558620E (pl)
WO (1) WO2004005304A1 (pl)
ZA (1) ZA200500908B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60022372T2 (de) * 1999-10-27 2006-06-08 The University Court Of The University Of Edinburgh Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
KR20060023526A (ko) 2003-04-30 2006-03-14 유니버시티 오브 코트 오브 더 유니버시티 오브 에딘버그 종양 치료를 위한 루테늄〔ii〕 착물
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
WO2007128158A1 (en) 2006-05-09 2007-11-15 Ecole Polytechnique Federale De Lausanne (Epfl) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
DE102009053392A1 (de) * 2009-11-14 2011-06-22 Umicore AG & Co. KG, 63457 Verfahren zur Herstellung von Ru(0) Olefin-Komplexen
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
CN103360428A (zh) * 2012-04-09 2013-10-23 中国科学院化学研究所 抑制蛋白酪氨酸磷酸酶1b活性的含钌配合物及其制备方法和蛋白酪氨酸磷酸酶1b抑制剂
CN102964385B (zh) * 2012-11-30 2015-02-18 广西师范学院 一种有机金属钌化合物及其制备方法和用途
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
DE69635874T2 (de) * 1995-12-06 2006-12-14 Japan Science And Technology Agency, Kawaguchi Verfahren zur Herstellung von optisch aktiven Alkoholen
DE60022372T2 (de) * 1999-10-27 2006-06-08 The University Court Of The University Of Edinburgh Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds

Also Published As

Publication number Publication date
DK1558620T3 (da) 2009-01-05
AU2003251159B2 (en) 2008-11-06
CA2491640A1 (en) 2004-01-15
ES2314245T3 (es) 2009-03-16
GB0215526D0 (en) 2002-08-14
ATE407937T1 (de) 2008-09-15
WO2004005304A1 (en) 2004-01-15
CN1665826A (zh) 2005-09-07
AU2003251159A1 (en) 2004-01-23
KR20050053589A (ko) 2005-06-08
JP2005536487A (ja) 2005-12-02
NO20050640L (no) 2005-03-22
EP1558620B1 (en) 2008-09-10
BR0312470A (pt) 2005-04-26
ZA200500908B (en) 2006-03-29
EP1558620A1 (en) 2005-08-03
MXPA05000314A (es) 2005-09-20
US20060058270A1 (en) 2006-03-16
CN100362005C (zh) 2008-01-16
NZ538005A (en) 2007-08-31
PT1558620E (pt) 2008-12-03
DE60323529D1 (de) 2008-10-23

Similar Documents

Publication Publication Date Title
ZA200500908B (en) Ruthenium anticancer complexes
RS50939B (sr) 2-fenil benzimidazoli i imidazo-/4,5/-piridini kao cdsi/chk2 -inhibitori i pomoćna sredstva u hemoterapiji ili terapiji zračenja pri lečenju kancera
HK1079519A1 (en) Furyl compounds
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
PL367682A1 (pl) Pochodne dolastatyny 10
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
WO2003106384A3 (en) NOVEL BORIC CHALCONE DERIVATIVES AND USES THEREOF
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
IL159993A0 (en) Platinum complexes and their use in cancer treatment
AU2003300385A8 (en) Anticancer compounds
MY130957A (en) Triazine derivatives and their application as antitelomerase agents
WO2000063219A8 (en) Platinum complexes for the treatment of cancer
HK1084954A1 (en) Ruthenium(II) complexes for the treatment of tumors
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
TW200504051A (en) Novel acridine derivatives and their use as medicaments
HK1088214A1 (en) Pmcol for the treatment of prostate cancer
MXPA06000372A (es) Compuestos de silicio y su uso.
MX2008001548A (es) Compuestos antitumorales.
GB0012795D0 (en) Organic compounds
GB0015446D0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
ATE336244T1 (de) Metallorganisches antitumormittel
WO2003014128A3 (de) Tumorhemmende cerverbindungen
DE60220504D1 (en) Tryptasehemmer
WO2004089300A3 (en) Sapphyrins and uses thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)